https://doi.org/10.1016/j.jpainsymman.2018.02.004
T
Talia Shentzer Kutiel
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
20
Papers
61
Citations
4
h-index
1
i10-index
Talia Shentzer Kutiel is an academic researcher from Technion – Israel Institute of Technology. The author has contributed to research in topics: Lung Cancer Research Studies & Peptidase Inhibition and Analysis & Cancer Immunotherapy and Biomarkers. The author has an h-index of 4, co-authored 17 publications.
Papers by this author
worksCannabis for Vismodegib-Related Muscle Cramps in a Patient With Advanced Basal Cell Carcinoma
2018 · Journal of Pain and Symptom Management · 7 citations
Comparative efficacy of immunotherapy-based treatment versus chemotherapy-only in patients with unresectable NSCLC with disease progression post chemoradiation and durvalumab
2025 · European Journal of Cancer · 5 citations
https://doi.org/10.1016/j.ejca.2025.115302
2792TiP A phase Ib/II study of gocatamig (MK-6070; HPN328) and ifinatamab deruxtecan for relapsed/refractory extensive-stage small cell lung cancer (ES-SCLC)
2025 · Annals of Oncology · 1 citations
https://doi.org/10.1016/j.annonc.2025.08.3403
1326P Clinical and genomic characteristics of advanced non-small cell lung cancer (aNSCLC) patients (pts) with long-term response to first-line (1L) immunotherapy: A real-world study
2024 · Annals of Oncology · 0 citations
https://doi.org/10.1016/j.annonc.2024.08.1381
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat